BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37231275)

  • 1. Do patients with metastatic renal cell carcinoma obtain survival benefits from cytoreductive nephrectomy? A population-based study.
    Luo Z; Jiao B; Xu Q; He W; Zhao H; Liu Y; Chen H; Guan Y; Zhang G; Jiang Z
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9657-9670. PubMed ID: 37231275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Nomogram Model to Identify Appropriate Candidates from Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Based on the Surveillance, Epidemiology and End Results Database.
    Ren K; Ning H; Wu HH; Wu F; Lyu JJ
    Clin Genitourin Cancer; 2024 Jun; 22(3):102062. PubMed ID: 38548487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and validation of a novel prognostic nomogram for patients with metastatic renal cell carcinoma: a SEER-based study.
    Lu Z; He W; Zhou J; Yang C; Xiang R
    J Int Med Res; 2022 Jun; 50(6):3000605221105367. PubMed ID: 35726570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: A population-based study.
    Hu Y; Xu S; Qi Q; Wang X; Meng J; Zhou J; Hao Z; Liang Q; Feng X; Liang C
    Front Public Health; 2022; 10():989566. PubMed ID: 36276376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomograms for predicting overall and cancer-specific survival of patients with chromophobe renal cell carcinoma after nephrectomy: a retrospective SEER-based study.
    Zheng J; Li S; Zhao Y; Tao Z; Li L; Li Z; Li M; Chen X
    BMJ Open; 2022 Sep; 12(9):e062129. PubMed ID: 36581979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic nomogram for patients with lung metastatic renal cell carcinoma: a SEER-based study.
    Mao W; Fu Z; Wang K; Wu J; Xu B; Chen M
    Ann Palliat Med; 2021 Mar; 10(3):2791-2804. PubMed ID: 33549017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy.
    Zhang Z; Wu H; Yang T; Wu Y; Yu N; Xu Z
    BMC Cancer; 2020 Sep; 20(1):844. PubMed ID: 32883242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
    Ma Q; Chen Z; Fang Y; Wei X; Wang N; Zhou X; Li S; Ying C
    J Endocrinol Invest; 2024 Jan; 47(1):115-129. PubMed ID: 37294407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a prognostic nomogram for adult patients with renal sarcoma: A retrospective study based on the SEER database.
    Zhu Y; Mao W; Zhang G; Sun S; Tao S; Jiang T; Wang Q; Meng Y; Wu J; Chen M
    Front Public Health; 2022; 10():942608. PubMed ID: 36187680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
    Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
    Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
    [No Abstract]   [Full Text] [Related]  

  • 11. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.
    Wang K; Wu Z; Wang G; Shi H; Xie J; Yin L; Xu T; Mao W; Peng B
    Int Braz J Urol; 2021; 47(2):333-349. PubMed ID: 33284535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
    Marconi L; de Bruijn R; van Werkhoven E; Beisland C; Fife K; Heidenreich A; Kapoor A; Karam J; Kauffmann C; Klatte T; Ljungberg B; Matin S; Sjoberg D; Staehler M; Stewart GD; Tanguay S; Uzzo R; Welsh S; Wood L; Wood C; Bex A
    World J Urol; 2018 Dec; 36(12):1973-1980. PubMed ID: 30069581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
    Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
    Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A web-based prognostic nomogram for the cancer specific survival of elderly patients with T1-T3N0M0 renal pelvic transitional cell carcinoma based on the surveillance, epidemiology, and end results database.
    Wang J; Tang J; Liu X; He D
    BMC Urol; 2022 May; 22(1):78. PubMed ID: 35610606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomograms for predicting long-term overall survival and cancer-specific survival in patients with primary urethral carcinoma: a population-based study.
    Zi H; Gao L; Yu Z; Wang C; Ren X; Lyu J; Li X
    Int Urol Nephrol; 2020 Feb; 52(2):287-300. PubMed ID: 31612421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of preoperative combined neutrophil, monocyte, and lymphocyte scores in patients with renal cell carcinoma undergoing laparoscopic nephrectomy: A retrospective study.
    Ni J; Yao X; Song W; Zhang H; Zhang H; Wang Y; Zhang Y; Wang G; Wang K; Mao W; Peng B
    Cancer Med; 2024 May; 13(9):e7214. PubMed ID: 38686610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Nomogram to Predict Cancer-Specific Survival in Elderly Patients With Papillary Renal Cell Carcinoma.
    Zhanghuang C; Wang J; Yao Z; Li L; Xie Y; Tang H; Zhang K; Wu C; Yang Z; Yan B
    Front Public Health; 2022; 10():874427. PubMed ID: 35444972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of prognostic nomograms for adult with papillary renal cell carcinoma: A retrospective study.
    Guo Q; Li S; Zhu J; Wang Z; Li Z; Wang J; Wen R; Li H
    Clinics (Sao Paulo); 2024; 79():100374. PubMed ID: 38718696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Primary Tumor Size on Prognosis in Patients With Metastatic Renal Cell Carcinoma Receiving Cytoreductive Nephrectomy: A Population Study of a Chinese Center and the US SEER Database.
    Jiang W; Shou J; Shi H; Wen L; Zhang H; Zheng S; Li C; Ma J
    Technol Cancer Res Treat; 2021; 20():15330338211019507. PubMed ID: 34032149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of prognostic risk factors in patients with SCCB using artificial intelligence: a retrospective study.
    Zhanghuang C; Zhang Z; Wang J; Yao Z; Ji F; Wu C; Ma J; Yang Z; Xie Y; Tang H; Yan B
    Sci Rep; 2023 May; 13(1):8727. PubMed ID: 37253772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.